Results 21 to 30 of about 29,547 (250)

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

Intrahepatic Sarcomatoid Cholangiocarcinoma [PDF]

Journal of Oncology, 2010
Intrahepatic sarcomatoid cholangiocarcinoma is a rare but an aggressive variant of cholangiocarcinoma with a very poor prognosis. We report the first caucasian patient who presented with a rapidly enlarging liver mass requiring hepatic resection. Detailed histopathological analyses including immunohistochemistry and electron microscopy confirmed ...
Malhotra, Shalini, Wood, Joanna, Mansy, Talal, Singh, Rajeev, Zaitoun, Abed, Madhusudan, Srinivasan   +5 more
openaire   +2 more sources

Proteogenomic characterization of cholangiocarcinoma

Hepatology, EarlyView., 2022
Proteogenomic characterization of cholangiocarcinoma with therapeutic strategies Abstract Background and Aims Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment ...
Mengjie Deng, Peng Ran, Lingli Chen, Yunzhi Wang, Zixiang Yu, Ke Cai, Jinwen Feng, Zhaoyu Qin, Yanan Yin, Subei Tan, Yang Liu, Chen Xu, Guoming Shi, Yuan Ji, Jian‐Yuan Zhao, Jian Zhou, Jia Fan, Yingyong Hou, Chen Ding   +18 more
wiley   +1 more source

Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis

Surgical Case Reports, 2023
Background Liver tumors with liver abscesses are unusual and rarely reported. In particular, studies of intrahepatic cholangiocarcinoma with liver abscesses due to hepatic actinomycosis have not been reported.
Tomoya Masuda, Kenta Kobashi, Ryoma Sugimoto, Hiroshi Ishii, Kensuke Tsunemitsu   +4 more
doaj   +1 more source

Asbestos and Intrahepatic Cholangiocarcinoma [PDF]

Cells, 2020
The link between asbestos exposure and the onset of thoracic malignancies is well established. However epidemiological studies have provided evidences that asbestos may be also involved in the development of gastrointestinal tumors, including intrahepatic cholangiocarcinoma (ICC). In line with this observation, asbestos fibers have been detected in the
Brandi G., Tavolari S.
openaire   +3 more sources

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

Medicina, 2021
Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further ...
Angela Dalia Ricci, Alessandro Rizzo
doaj   +1 more source

Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma. [PDF]

, 2009
BACKGROUND: The present study aimed to elucidate the relationship between microvessel count (MVC) according to CD34 expression and prognosis in intrahepatic cholangiocarcinoma (ICC) patients who underwent hepatectomy based on our preliminary study ...
Nanashima, Atsushi, Kunizaki, Masaki, Takeshita, Hiroaki, Sawai, Terumitsu, Nagayasu, Takeshi, Tobinaga, Syuichi, Araki, Masato, Nakayama, Toshiyuki, Hidaka, Shigekazu, Shibata, Kenichiro, Tagawa, Tsutomu   +10 more
core   +1 more source

Intrahepatic Cholangiocarcinoma

Techniques in Vascular and Interventional Radiology, 2015
Cholangiocarcinoma is a rare malignancy that arises from epithelial cells of the biliary system. Its desmoplastic histology and the heterogeneity of its presentation have contributed to its poor prognosis, with limited therapeutic options previously available.
A. B. Luk’yanchenko, B. M. Medvedeva, M. A. Shabanov, E. R. Virshke, V. V. Breder, K. A. Romanova   +5 more
openaire   +5 more sources

Intrahepatic cholangiocarcinoma developing seven years after resection of congenital biliary dilatation

Journal of Pediatric Surgery Case Reports, 2020
A 13-year-old girl developed intrahepatic cholangiocarcinoma 7 years after laparoscopic extrahepatic bile duct resection and biliary reconstruction to treat Todani's type IV-A congenital biliary dilatation (CBD).
Kanako Omata, Tetsuya Ishimaru, Akiko Nakazawa, Yuichi Mitani, Makiko Mori, Nobuhisa Akamatsu, Katsuyoshi Koh, Hiroshi Kawashima, Kiyoshi Hasegawa   +8 more
doaj   +1 more source

Staging of intrahepatic cholangiocarcinoma [PDF]

HepatoBiliary Surgery and Nutrition, 2017
Intrahepatic cholangiocarcinoma (ICC) comprises approximately 5-30% of primary liver tumors, however it has been increasing over the last several decades. Up to and including the 6th edition of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) edition staging system, ICC was staged the same as hepatocellular ...
Sean M, Ronnekleiv-Kelly, Timothy M, Pawlik   +1 more
openaire   +2 more sources